Medindia

X

Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase

by Savitha C Muppala on  June 3, 2011 at 10:42 PM Cancer News   - G J E 4
A new drug to treat triple-negative breast cancer is ready to undergo testing.

A group of 15 genes responsible for accelerating the growth of cancer has been found by researchers at the Dana-Farber Cancer Institute in Boston.
 Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase
Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase
Advertisement

This finding has paved the way for clinical trials on a drug which promises to retard or stop the development of triple-negative breast cancer tumors.

Advertisement
Currently, triple negative breast cancers affects more than 40,000 women annually. With these clinical trials, researchers are hoping to arrive at specific therapies to treat triple-negative breast cancers effectively.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All